BioSpace News Archive

Osteoarthritis, or Degenerative Joint Disease, is a disease characterized by the destruction of the protective lining that covers the bone in a movable joint.

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that the Company will host a key opinion leader (KOL) breakfast symposium on Thursday, July 11, 2019 at 8:00 a.m. ET in New York City.

Pravin will oversee Amplity’s company’s overall technology direction and development and will lead the technology, business systems, security, and infrastructure teams.

A dual listing will provide increased awareness of Abacus in the public markets, access to a large new pool of potential investors and also enhance liquidity.

The transaction is subject to customary closing conditions.

AAIC is the premier annual conference for presentation and discussion of the latest Alzheimer’s and dementia research.

Company to repurchase common stock from funds managed by affiliates of KKR & Co., Inc.

Dr. Kerstein is a global expert on the use and application of the T-Scan™ digital occlusal analysis system, and a pioneer and academic science advocate for digital occlusal technology.

Medidata Rave Clinical Cloud™ to help spearhead the company’s biologics transformation

IceCure Medical Ltd. (TASE: ICCM), developer of the next generation liquid-nitrogen-based cryoablation technology to treat malignant and benign tumors by freezing, announced today that its application for a new CPT code, describing the use of cryoablation for treating cancerous breast tumors, has been approved by the American Medical Association